Insider · CIK 0001615374

OrbiMed Capital GP V LLC

CIK 0001615374 Name as filed on the most recent filing

Filed as OrbiMed Capital GP V LLC (61)

115 transaction lines · from 61 filings · filed 2014-08-06 to 2026-04-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-03-03 S, Open-market sale Inspire Medical Systems, Inc.INSP 2,113,750, disposed Open Form 4 filing 0000947871-20-000192
2019-12-11 S, Open-market sale Tricida, Inc.TCDA 60,000,000, disposed Open Form 4 filing 0000947871-19-000959
2019-11-27 S, Open-market sale Inspire Medical Systems, Inc.INSP 3 lines 3,823,990, disposed Open Form 4 filing 0000947871-19-000876
2019-11-26 S, Open-market sale Inspire Medical Systems, Inc.INSP 2 lines 4,941,926, disposed Open Form 4 filing 0000947871-19-000876
2019-08-06 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 500,723, acquired Open Form 4 filing 0000947871-19-000571
2019-07-01 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 231,640, acquired Open Form 4 filing 0000947871-19-000486
2019-06-28 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 2,102,462, acquired Open Form 4 filing 0000947871-19-000486
2019-06-27 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 109,963, acquired Open Form 4 filing 0000947871-19-000486
2019-04-03 P, Open-market purchase Tricida, Inc.TCDA 8,100,000, acquired Open Form 4 filing 0000947871-19-000271
2019-03-08 S, Open-market sale Inspire Medical Systems, Inc.INSP 16,760,840, disposed Open Form 4 filing 0000947871-19-000201
2019-03-07 S, Open-market sale Inspire Medical Systems, Inc.INSP 3,752,672, disposed Open Form 4 filing 0000947871-19-000201
2018-12-11 S, Open-market sale Inspire Medical Systems, Inc.INSP 23,115,427, disposed Open Form 4 filing 0000947871-18-000971
2018-10-19 P, Open-market purchase Si-Bone, Inc.SIBN 3,000,000, acquired Open Form 4 filing 0001209191-18-055701
2018-07-02 P, Open-market purchase Tricida, Inc.TCDA 6,999,999, acquired Open Form 4 filing 0001140361-18-031065
2018-06-28 P, Open-market purchase Aerpio Pharmaceuticals, Inc.ARPO 2,993,375, acquired Open Form 4 filing 0000947871-18-000542
2018-06-06 S, Open-market sale Adaptimmune Therapeutics PLCADAP 21,584, disposed Open Form 4 filing 0000947871-18-000492
2018-06-04 S, Open-market sale Adaptimmune Therapeutics PLCADAP 232,047, disposed Open Form 4 filing 0000947871-18-000492
2018-06-01 S, Open-market sale Adaptimmune Therapeutics PLCADAP 674,500, disposed Open Form 4 filing 0000947871-18-000482
2018-05-30 S, Open-market sale Adaptimmune Therapeutics PLCADAP 1,635,920, disposed Open Form 4 filing 0000947871-18-000482
2018-05-22 S, Open-market sale Rhythm Pharmaceuticals, Inc.RYTM 2 lines 595,768, disposed Open Form 4 filing 0000947871-18-000450
2018-05-21 S, Open-market sale Rhythm Pharmaceuticals, Inc.RYTM 1,938,125, disposed Open Form 4 filing 0000947871-18-000439
2018-05-18 S, Open-market sale Rhythm Pharmaceuticals, Inc.RYTM 2,127,315, disposed Open Form 4 filing 0000947871-18-000439
2018-05-14 S, Open-market sale Adaptimmune Therapeutics PLCADAP 139,050, disposed Open Form 4 filing 0000947871-18-000422
2018-05-07 P, Open-market purchase Inspire Medical Systems, Inc.INSP 5,000,000, acquired Open Form 4 filing 0001104659-18-031867
2018-03-29 S, Open-market sale Adaptimmune Therapeutics PLCADAP 368,764, disposed Open Form 4 filing 0000947871-18-000307
2018-03-27 S, Open-market sale Adaptimmune Therapeutics PLCADAP 11,684,966, disposed Open Form 4 filing 0000947871-18-000307
2018-03-12 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 4,999,998, acquired Open Form 4 filing 0000947871-18-000244
2017-12-08 S, Open-market sale Loxo Oncology, Inc.LOXO 20,625,000, disposed Open Form 4 filing 0000947871-17-000998
2017-11-22 S, Open-market sale Loxo Oncology, Inc.LOXO 20,025,000, disposed Open Form 4 filing 0000947871-17-000969
2017-11-16 S, Open-market sale Loxo Oncology, Inc.LOXO 5 lines 20,051,389, disposed Open Form 4 filing 0000947871-17-000953
2017-10-10 P, Open-market purchase Rhythm Pharmaceuticals, Inc.RYTM 6,035,000, acquired Open Form 4 filing 0001104659-17-061573
2017-03-27 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 4,999,999, acquired Open Form 4 filing 0000947871-17-000255
2017-03-15 P, Open-market purchase Aerpio Pharmaceuticals, Inc.NONE 3,814,975, acquired Open Form 4 filing 0000899243-17-008159
2017-02-21 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 37,520, acquired Open Form 4 filing 0000947871-17-000160
2017-02-17 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 372,642, acquired Open Form 4 filing 0000947871-17-000160
2017-02-16 P, Open-market purchase Aeglea BioTherapeutics, Inc.AGLE 153,720, acquired Open Form 4 filing 0000947871-17-000160
2016-08-10 S, Open-market sale Loxo Oncology, Inc.LOXO 12,074,225, disposed Open Form 4 filing 0000947871-16-001416
2016-06-24 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 11,691, acquired Open Form 4 filing 0000947871-16-001306
2016-06-23 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 1,292, acquired Open Form 4 filing 0000947871-16-001306
2016-06-21 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 335,688, acquired Open Form 4 filing 0000947871-16-001289
2016-06-17 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 153,504, acquired Open Form 4 filing 0000947871-16-001289
2016-06-16 P, Open-market purchase Corvus Pharmaceuticals, Inc.CRVS 60,200, acquired Open Form 4 filing 0000947871-16-001266

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. OrbiMed Capital GP V LLC, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001615374

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.